Drug details
Nulibry (fosdenopterin for injection)
type of Enzymes, Metabolic
Nulibry (fosdenopterin) is cyclic pyranopterin monophosphate (cPMP) indicated to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.
This drug may have the following side effects:
- vomiting,
- fever,
- diarrhea
- cough,
- pneumonia,
- sneezing,
- Nulibry (fosdenopterin) for Injectioncatheter-related complications,
- viral infection,
- middle ear infection,
- viral upper respiratory infection,
- gastroenteritis,
- bacteremia, and